Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Feliza Bourguet is active.

Publication


Featured researches published by Feliza Bourguet.


Protein Science | 2011

Characterizing diffusion dynamics of a membrane protein associated with nanolipoproteins using fluorescence correlation spectroscopy.

Tingjuan Gao; Craig D. Blanchette; Wei He; Feliza Bourguet; Sonny Ly; Federico Katzen; Wieslaw Kudlicki; Paul T. Henderson; Ted A. Laurence; Thomas Huser; Matthew A. Coleman

Nanolipoprotein particles (NLPs) represent a unique nanometer‐sized scaffold for supporting membrane proteins (MP). Characterization of their dynamic shape and association with MP in solution remains a challenge. Here, we present a rapid method of analysis by fluorescence correlation spectroscopy (FCS) to characterize bacteriorhodopsin (bR), a membrane protein capable of forming a NLP complex. By selectively labeling individual components of NLPs during cell‐free synthesis, FCS enabled us to measure specific NLP diffusion times and infer size information for different NLP species. The resulting bR‐loaded NLPs were shown to be dynamically discoidal in solution with a mean diameter of 7.8 nm. The insertion rate of bR in the complex was ∼55% based on a fit model incorporating two separate diffusion properties to best approximate the FCS data. More importantly, based on these data, we infer that membrane protein associated NLPs are thermodynamically constrained as discs in solution, while empty NLPs appear to be less constrained and dynamically spherical.


Journal of Physical Chemistry B | 2014

Fluorescence Correlation Spectroscopy at Micromolar Concentrations without Optical Nanoconfinement

Ted A. Laurence; Sonny Ly; Feliza Bourguet; Nicholas O. Fischer; Matthew A. Coleman

Fluorescence correlation spectroscopy (FCS) is an important technique for studying biochemical interactions dynamically that may be used in vitro and in cell-based studies. It is generally claimed that FCS may only be used at nM concentrations. We show that this general consensus is incorrect and that the limitation to nM concentrations is not fundamental but due to detector limits as well as laser fluctuations. With a high count rate detector system and applying laser fluctuation corrections, we demonstrate FCS measurements up to 38 μM with the same signal-to-noise as at lower concentrations. Optical nanoconfinement approaches previously used to increase the concentration range of FCS are not necessary, and further increases above 38 μM may be expected using detectors and detector arrays with higher saturation rates and better laser fluctuation corrections. This approach greatly widens the possibilities of dynamic measurements of biochemical interactions using FCS at physiological concentrations.


Applied and Environmental Microbiology | 2012

Characterization of a Novel Lytic Protein Encoded by the Bacillus cereus E33L Gene ampD as a Bacillus anthracis Antimicrobial Protein

Feliza Bourguet; Brian Souza; Angela K. Hinz; Matthew A. Coleman; Paul J. Jackson

ABSTRACT Lytic proteins encoded by bacterial genomes have been implicated in cell wall biosynthesis and recycling. The Bacillus cereus E33L ampD gene encodes a putative N-acetylmuramoyl-l-alanine amidase. This gene, expressed in vitro, produced a very stable, highly active lytic protein. Very low concentrations rapidly and efficiently lyse vegetative Bacillus anthracis cells.


Protein Science | 2013

Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistry

Wei He; Juntao Luo; Feliza Bourguet; Li Xing; Sun K. Yi; Tingjuan Gao; Craig D. Blanchette; Paul T. Henderson; Edward A. Kuhn; Mike Malfatti; William J. Murphy; R. Holland Cheng; Kit S. Lam; Matthew A. Coleman

Nanolipoprotein particles (NLPs) are nanometer‐scale discoidal particles that feature a phospholipid bilayer confined within an apolipoprotein “scaffold,” which are useful for solubilizing hydrophobic molecules such as drugs and membrane proteins. NLPs are synthesized either by mixing the purified apolipoprotein with phospholipids and other cofactors or by cell‐free protein synthesis followed by self‐assembly of the nanoparticles in the reaction mixture. Either method can be problematic regarding the production of homogeneous and monodispersed populations of NLPs, which also currently requires multiple synthesis and purification steps. Telodendrimers (TD) are branched polymers made up of a dendritic oligo‐lysine core that is conjugated to linear polyethylene glycol (PEG) on one end, and the lysine “branches” are terminated with cholic acid moieties that enable the formation of nanomicelles in aqueous solution. We report herein that the addition of TD during cell‐free synthesis of NLPs produces unique hybrid nanoparticles that have drastically reduced polydispersity as compared to NLPs made in the absence of TD. This finding was supported by dynamic light scattering, fluorescence correlation spectroscopy, and cryo transmission electron microscopy (Cryo‐EM). These techniques demonstrate the ability of TDs to modulate both the NLP size (6–30 nm) and polydispersity. The telodendrimer NLPs (TD‐NLPs) also showed 80% less aggregation as compared to NLPs alone. Furthermore, the versatility of these novel nanoparticles was shown through direct conjugation of small molecules such as fluorescent dyes directly to the TD as well as the insertion of a functional membrane protein.


Journal of Biological Chemistry | 2017

Cell-free production of a functional oligomeric form of a chlamydia major outer membrane protein (MOMP) for vaccine development

Wei He; Martina Felderman; Angela C. Evans; Jia Geng; David Homan; Feliza Bourguet; Nicholas O. Fischer; Yuanpei Li; Kit S. Lam; Aleksandr Noy; Li Xing; R. Holland Cheng; Amy Rasley; Craig D. Blanchette; Kurt I. Kamrud; Nathaniel Wang; Heather Gouvis; Todd Peterson; Bolyn Hubby; Matthew A. Coleman

Chlamydia is a prevalent sexually transmitted disease that infects more than 100 million people worldwide. Although most individuals infected with Chlamydia trachomatis are initially asymptomatic, symptoms can arise if left undiagnosed. Long-term infection can result in debilitating conditions such as pelvic inflammatory disease, infertility, and blindness. Chlamydia infection, therefore, constitutes a significant public health threat, underscoring the need for a Chlamydia-specific vaccine. Chlamydia strains express a major outer-membrane protein (MOMP) that has been shown to be an effective vaccine antigen. However, approaches to produce a functional recombinant MOMP protein for vaccine development are limited by poor solubility, low yield, and protein misfolding. Here, we used an Escherichia coli-based cell-free system to express a MOMP protein from the mouse-specific species Chlamydia muridarum (MoPn-MOMP or mMOMP). The codon-optimized mMOMP gene was co-translated with Δ49apolipoprotein A1 (Δ49ApoA1), a truncated version of mouse ApoA1 in which the N-terminal 49 amino acids were removed. This co-translation process produced mMOMP supported within a telodendrimer nanolipoprotein particle (mMOMP–tNLP). The cell-free expressed mMOMP–tNLPs contain mMOMP multimers similar to the native MOMP protein. This cell-free process produced on average 1.5 mg of purified, water-soluble mMOMP–tNLP complex in a 1-ml cell-free reaction. The mMOMP–tNLP particle also accommodated the co-localization of CpG oligodeoxynucleotide 1826, a single-stranded synthetic DNA adjuvant, eliciting an enhanced humoral immune response in vaccinated mice. Using our mMOMP–tNLP formulation, we demonstrate a unique approach to solubilizing and administering membrane-bound proteins for future vaccine development. This method can be applied to other previously difficult-to-obtain antigens while maintaining full functionality and immunogenicity.


PLOS ONE | 2016

Identification of Genome-Wide Mutations in Ciprofloxacin-Resistant F. tularensis LVS Using Whole Genome Tiling Arrays and Next Generation Sequencing

Crystal Jaing; Kevin S. McLoughlin; James B. Thissen; Adam Zemla; Shea N. Gardner; Lisa M. Vergez; Feliza Bourguet; Shalini Mabery; Viacheslav Y. Fofanov; Heather Koshinsky; Paul J. Jackson

Francisella tularensis is classified as a Class A bioterrorism agent by the U.S. government due to its high virulence and the ease with which it can be spread as an aerosol. It is a facultative intracellular pathogen and the causative agent of tularemia. Ciprofloxacin (Cipro) is a broad spectrum antibiotic effective against Gram-positive and Gram-negative bacteria. Increased Cipro resistance in pathogenic microbes is of serious concern when considering options for medical treatment of bacterial infections. Identification of genes and loci that are associated with Ciprofloxacin resistance will help advance the understanding of resistance mechanisms and may, in the future, provide better treatment options for patients. It may also provide information for development of assays that can rapidly identify Cipro-resistant isolates of this pathogen. In this study, we selected a large number of F. tularensis live vaccine strain (LVS) isolates that survived in progressively higher Ciprofloxacin concentrations, screened the isolates using a whole genome F. tularensis LVS tiling microarray and Illumina sequencing, and identified both known and novel mutations associated with resistance. Genes containing mutations encode DNA gyrase subunit A, a hypothetical protein, an asparagine synthase, a sugar transamine/perosamine synthetase and others. Structural modeling performed on these proteins provides insights into the potential function of these proteins and how they might contribute to Cipro resistance mechanisms.


PLOS ONE | 2016

Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles

Matthew A. Coleman; Jenny A. Cappuccio; Craig D. Blanchette; Tingjuan Gao; Erin S. Arroyo; Angela K. Hinz; Feliza Bourguet; Brent W. Segelke; Paul D. Hoeprich; Thomas Huser; Ted A. Laurence; Vladimir L. Motin; Brett A. Chromy

Yersinia pestis enters host cells and evades host defenses, in part, through interactions between Yersinia pestis proteins and host membranes. One such interaction is through the type III secretion system, which uses a highly conserved and ordered complex for Yersinia pestis outer membrane effector protein translocation called the injectisome. The portion of the injectisome that interacts directly with host cell membranes is referred to as the translocon. The translocon is believed to form a pore allowing effector molecules to enter host cells. To facilitate mechanistic studies of the translocon, we have developed a cell-free approach for expressing translocon pore proteins as a complex supported in a bilayer membrane mimetic nano-scaffold known as a nanolipoprotein particle (NLP) Initial results show cell-free expression of Yersinia pestis outer membrane proteins YopB and YopD was enhanced in the presence of liposomes. However, these complexes tended to aggregate and precipitate. With the addition of co-expressed (NLP) forming components, the YopB and/or YopD complex was rendered soluble, increasing the yield of protein for biophysical studies. Biophysical methods such as Atomic Force Microscopy and Fluorescence Correlation Spectroscopy were used to confirm that the soluble YopB/D complex was associated with NLPs. An interaction between the YopB/D complex and NLP was validated by immunoprecipitation. The YopB/D translocon complex embedded in a NLP provides a platform for protein interaction studies between pathogen and host proteins. These studies will help elucidate the poorly understood mechanism which enables this pathogen to inject effector proteins into host cells, thus evading host defenses.


Biodegradation | 2009

Identification of c -type cytochromes involved in anaerobic, bacterial U(IV) oxidation

Harry R. Beller; Tina C. Legler; Feliza Bourguet; Tracy E. Letain; Staci R. Kane; Matthew A. Coleman


Biophysical Journal | 2014

Quantifying Interactions of a Membrane Protein Embedded in a Lipid Nanodisc using Fluorescence Correlation Spectroscopy

Sonny Ly; Feliza Bourguet; Nicholas O. Fischer; Edmond Y. Lau; Matthew A. Coleman; Ted A. Laurence


Microbial Cell Factories | 2017

Re-directing bacterial microcompartment systems to enhance recombinant expression of lysis protein E from bacteriophage ϕX174 in Escherichia coli

Mimi C. Yung; Feliza Bourguet; Timothy S. Carpenter; Matthew A. Coleman

Collaboration


Dive into the Feliza Bourguet's collaboration.

Top Co-Authors

Avatar

Matthew A. Coleman

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Craig D. Blanchette

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Paul J. Jackson

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Ted A. Laurence

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Angela K. Hinz

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Nicholas O. Fischer

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Sonny Ly

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Tingjuan Gao

University of California

View shared research outputs
Top Co-Authors

Avatar

Wei He

University of California

View shared research outputs
Top Co-Authors

Avatar

Brent W. Segelke

Lawrence Livermore National Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge